VeriMomisopropylbenzyl salicylate hamilelikte güvenli mi?
No harmonised ECHA Annex VI reproductive classification was identified and there is no CIR or SCCS safety conclusion indicating reproductive hazard for isopropylbenzyl salicylate (CAS 94134-93-7). Available chemical listings (ECHA registration/CosIng/PubChem) and the lack of peer-reviewed evidence of developmental/reproductive toxicity support no identified reproductive hazard. Topical cosmetic use can produce low but measurable exposure; therefore exposure scored as 1. Sources consulted: ECHA registration information (no harmonised CLP), CosIng, PubChem, PubMed (no reproductive/toxicity studies located).
Pregnancy-safe products containing isopropylbenzyl salicylate
Related ingredients
Frequently asked questions
- isopropylbenzyl salicylate hamilelikte güvenli mi?
- No harmonised ECHA Annex VI reproductive classification was identified and there is no CIR or SCCS safety conclusion indicating reproductive hazard for isopropylbenzyl salicylate (CAS 94134-93-7). Available chemical listings (ECHA registration/CosIng/PubChem) and the lack of peer-reviewed evidence of developmental/reproductive toxicity support no identified reproductive hazard. Topical cosmetic use can produce low but measurable exposure; therefore exposure scored as 1. Sources consulted: ECHA registration information (no harmonised CLP), CosIng, PubChem, PubMed (no reproductive/toxicity studies located).
- isopropylbenzyl salicylate emzirirken güvenli mi?
- No evidence of reproductive or lactation-specific toxicity or harmonised classification. Mechanistic data indicating transfer into breast milk were not found. For topical cosmetic use, low but measurable systemic exposure is plausible, so exposure scored as 1. Sources: ECHA registration/CosIng/PubChem and PubMed (no lactation transfer data).
- isopropylbenzyl salicylate bebek cildi için güvenli mi?
- No infant-specific toxicology or harmonised reproductive hazards identified. Mechanistic evidence of reproductive activity was not found. Because infants (0–3 yr) have an immature skin barrier and higher surface-area-to-weight ratio, exposure was increased by +1 relative to adult topical exposure (adult e=1 → baby e=2). Sources: ECHA registration/CosIng/PubChem and absence of SCCS/CIR adverse findings in the regulatory literature; PubMed search returned no infant-specific safety concerns.
- VeriMom isopropylbenzyl salicylate nasıl puanlıyor?
- VeriMom isopropylbenzyl salicylate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte isopropylbenzyl salicylate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.